Cargando…

Real-world comparison of clopidogrel, prasugrel and ticagrelor in patients undergoing primary percutaneous coronary intervention

BACKGROUND: There is a paucity of real-world outcome data comparing clopidogrel, prasugrel and ticagrelor in primary percutaneous coronary intervention (PPCI) for ST-segment elevation myocardial infarction (STEMI). We sought to assess the association of choice of oral P2Y12-receptor inhibitor with c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Krishnamurthy, Arvindra, Keeble, Claire, Anderson, Michelle, Somers, Kathryn, Burton-Wood, Natalie, Harland, Charlotte, Baxter, Paul, McLenachan, Jim, Blaxill, Jonathan, Blackman, Daniel J, Malkin, Christopher, Wheatcroft, Stephen, Greenwood, John
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2019
Materias:	Interventional Cardiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6609142/ https://www.ncbi.nlm.nih.gov/pubmed/31328001 http://dx.doi.org/10.1136/openhrt-2018-000951

Ejemplares similares

Association between operator volume and mortality in primary percutaneous coronary intervention
por: Krishnamurthy, Arvindra, et al.
Publicado: (2022)

Comparison of lower loading dose of prasugrel with conventional loading dose of prasugrel in Indian patients undergoing percutaneous coronary interventions
por: Kumari, Priti, et al.
Publicado: (2018)

Bleeding events and maintenance dose of prasugrel: BLESS pilot study
por: Carrabba, Nazario, et al.
Publicado: (2016)

Ticagrelor-induced Angioedema After Percutaneous Coronary Intervention in a Patient with a History of Ischemic Stroke and Low Response to Clopidogrel: A Rare Dilemma
por: Piranavan, Paramarajan, et al.
Publicado: (2018)

Correction: Real-world comparison of clopidogrel, prasugrel and ticagrelor in patients undergoing primary percutaneous coronary intervention
Publicado: (2019)

Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndrome and on Dialysis: A Meta-Analysis
por: Chenna, Venkata Sai Harshabhargav, et al.
Publicado: (2023)

No Differences in Gastrointestinal Bleeding Risk among Clopidogrel-, Ticagrelor-, or Prasugrel-Based Dual Antiplatelet Therapy
por: Laredo, Viviana, et al.
Publicado: (2020)

Long-term use of clopidogrel versus ticagrelor or prasugrel in patients with acute myocardial infarction after percutaneous coronary intervention
por: Kim, Yuri, et al.
Publicado: (2023)

Percutaneous balloon aortic valvuloplasty in the era of transcatheter aortic valve implantation: a narrative review
por: Keeble, Thomas R, et al.
Publicado: (2016)

Influence of METHoxyflurane on ANtiplatelet Effect of ticagrelor in patients with unstable angina pectoris: Rationale and a protocol of a randomized clinical METHANE-SIRIO 4 study
por: Niezgoda, Piotr, et al.
Publicado: (2022)

Incidence of cardiovascular events and gastrointestinal bleeding in patients receiving clopidogrel with and without proton pump inhibitors: an updated meta-analysis
por: Cardoso, Rhanderson N, et al.
Publicado: (2015)

Stent Thrombosis Patients with Hyporesponsiveness to Clopidogrel, Prasugrel, and Ticagrelor: A Case Series Using Short Thromboelastography
por: Olechowski, Bartosz, et al.
Publicado: (2016)

The Effect of Ticagrelor on Endothelial Function Compared to Prasugrel, Clopidogrel, and Placebo: A Systematic Review and Meta-Analysis
por: Guan, Baoyi, et al.
Publicado: (2022)

Early clinical outcomes as a function of use of newer oral P2Y(12) inhibitors versus clopidogrel in the EUROMAX trial
por: Huber, Kurt, et al.
Publicado: (2017)

Effects of clopidogrel, prasugrel and ticagrelor on prevention of stent thrombosis in patients underwent percutaneous coronary intervention: A network meta‐analysis
por: Chen, Wenwen, et al.
Publicado: (2021)

De-escalation therapy after acute coronary syndrome: is it reasonable to switch from prasugrel (or ticagrelor) to clopidogrel early?
por: Masiero, Giulia, et al.
Publicado: (2020)

Use of Clopidogrel, Prasugrel, or Ticagrelor and Patient Outcome after Acute Coronary Syndrome in Austria from 2015 to 2017
por: Rezaei, Safoura Sheikh, et al.
Publicado: (2020)

Comparison of Clopidogrel With Prasugrel and Ticagrelor in Patients With Acute Coronary Syndrome: Clinical Outcomes From the National Cardiovascular Database ACTION Registry
por: Khayata, Mohamed, et al.
Publicado: (2017)

Comparative Effectiveness of Ticagrelor, Prasugrel, and Clopidogrel for Secondary Prophylaxis in Acute Coronary Syndrome: A Propensity Score‐Matched Cohort Study
por: Kumar, Arun, et al.
Publicado: (2022)

Ticagrelor-Induced Syncope/Bradyarrhythmia
por: Kotaru, VeeraPavan, et al.
Publicado: (2021)

Complete percutaneous repair after valvular surgery
por: Moreno-Samos, Jose Carlos, et al.
Publicado: (2019)

The Pharmacokinetics and Pharmacodynamics of Prasugrel and Clopidogrel in Healthy Japanese Volunteers
por: Umemura, Kazuo, et al.
Publicado: (2016)

Coronary artery height differences and their effect on fractional flow reserve
por: Al-Janabi, Firas, et al.
Publicado: (2021)

Efficacy and safety comparing prasugrel/ticagrelor and clopidogrel in Hong Kong post‐acute coronary syndrome patients–A 10‐year cohort study
por: Lam, Amy S. M., et al.
Publicado: (2021)

Creatine kinase during non-ST-segment elevation acute coronary syndromes is associated with major bleeding
por: Brewster, Lizzy Maritza, et al.
Publicado: (2020)

Predictors of success in percutaneous Coronary intervention for chronic total occlusion
por: Mehta, Ashwin B., et al.
Publicado: (2018)

Non-hyperaemic pressure ratios to guide percutaneous coronary intervention
por: Michail, Michael, et al.
Publicado: (2020)

Percutaneous closure of “hidden” left atrial appendage with Ultraseal device
por: Moreno-Samos, Jose Carlos, et al.
Publicado: (2019)

Percutaneous removal of a catheter fragment from the right atrium
por: Pietrasik, Arkadiusz, et al.
Publicado: (2021)

Incidence and prognosis of late readmission after percutaneous coronary intervention
por: Freites, Alfonso, et al.
Publicado: (2023)

Ulnar artery thrombosis after percutaneous thrombin injection of a pseudoaneurysm with a concomitant radial artery occlusion: Three complications after percutaneous coronary intervention
por: Di Giorgio, Angela, et al.
Publicado: (2023)

Colchicine for symptomatic coronary artery disease after percutaneous coronary intervention
por: Aw, Kah Long, et al.
Publicado: (2022)

The effect of bivalirudin and closure device on bleeding outcomes after percutaneous coronary interventions
por: Dobies, David R, et al.
Publicado: (2014)

Premedication to reduce anxiety in patients undergoing coronary angiography and percutaneous coronary intervention
por: Vlastra, Wieneke, et al.
Publicado: (2018)

Prophylactic percutaneous circulatory support in high risk transcatheter aortic valve implantation
por: Castrodeza, Javier, et al.
Publicado: (2019)

Successful percutaneous mechanical thrombectomy of an Impella CP-related femoral artery thrombosis
por: Degrauwe, Sophie, et al.
Publicado: (2021)

Post-percutaneous coronary intervention angina: From physiopathological mechanisms to individualized treatment
por: De Luca, Leonardo, et al.
Publicado: (2022)

Percutaneous coronary intervention of chronic total occlusion and bifurcation: Different strategies to succeed
por: Boudou, Nicolas, et al.
Publicado: (2023)

In-hospital outcome of re-attempted percutaneous coronary interventions for chronic total occlusion
por: Guelker, Jan-Erik, et al.
Publicado: (2023)

Differences of in-hospital outcomes within patients undergoing percutaneous coronary intervention at institutions with high versus low procedural volume: a report from the Japanese multicentre percutaneous coronary intervention registry
por: Kodaira, Masaki, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_l5tllo531ao2rs3fhct3q97rnh